Trial intelligence / Profile preview

PCV Followed by PPV vs PPV Alone in HIV-infected Adults

NCT00148824Phase 2Completed

Sponsor
ANRS
Start
Feb 2003
Modality
Split/Subunit Vaccines
Countries
1
01

Overview

Phase 2, randomised trial of pneumococcal 7-valent conjugate vaccine in pneumococcal infection (2 arms), sponsored by ANRS. Primary endpoint: Proportion of patients responders to 7 pneumococcal polysaccharides at 8 weeks. Started Feb 2003; status: completed.

02

Drugs

pneumococcal 7-valent conjugate vaccine
03

Conditions

pneumococcal infection

Beyond the preview

Go deeper on NCT00148824.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00148824.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call